For effective tracking of the health status of a high-risk population of PD, such as people with a family history of PD, using α-synuclein may be helpful in the early diagnosis of PD and the monitoring of disease progression during treatment, so as to provide a basis for new treatment as well as theoretical guidance for the further study on the pathogenesis of PD. Here, SNCA is linked to Parkinson disease.